Human c-myc cDNA was fused with the hormone-binding domain (HBD) cDNA of murine estrogen receptor gene and the chimeric gene was introduced into the CHO cells. The fusion protein, c-MycER, becomes activated when the synthetic steroid, 4-hydroxy-tamoxifen (OHT), binds HBD. Activated cMycER, likely c-Myc, can induce quiescent CHO cells reentry into S phase and subsequent cell death under serum-free condition. In addition, the expression of some proposed c-myc target genes such as ODC, MrDb, cad, rcc1 and rcl were found to increase upon OHT induction before S phase entry and apoptosis, indicating that these target genes are involved in cell cycle regulation and/or apoptosis control. However, the mutant D106-143c-MycER protein does not have above activities.
INTRODUCTION
The c-myc proto-oncogene, the cellular homologue of the gene born by the retrovirus MC29, is responsible for chicken leukemia [1] , and it originally got its name for the ability to causemyelocytomatosis in susceptible animals and cultured cells [2] . c-myc is one of the most widely studied and the best-characterized proto-oncogene. Although c-myc has been shown closely related to cell growth, differentiation, cell cycle progression, tumorigenesis and apoptosis, the authentic functions of c-Myc protein have still been obscure.
However, the elucidation of bHLHLZ structure in c-Myc and the discoveries of partner proteins of c-Myc in recent years promoted a new approach to understand this old proto-oncogene. C-Myc protein, likely other bHLHLZ proteins, possesses specific DNAbinding activity to CACGTG (E-box) sequence. C-Myc is therefore supposed to function as a transcription regulator, while cooperating with its partner(s) including Max and Mad family [3] . It is agreed that c-Myc dimerizes with Max to bind CACGTG or similar consensus sequence of down stream target genes thereby regulating transcription and subsequently promoting cell proliferation and apoptosis, as well as inhibiting cell differentiation. Dozen of c-myc target genes have been proposed including p53 [4] , ODC [5] , α-prothymosin [6] , ECA39 [7] , cad [8] , eIF-2a [9] , cdc25A [10] , MrDb [11] , rcc1 [12] , rcl [13] and TERT [14] , [15] . The list is increasing each year.
To understand how c-myc involved in cell growth and death, we established a function-inducible c-myc over expression system in CHO cells in which human c-myc was fused with the hormone binding domain (HBD) cDNA of estrogen receptor gene [16] . The produced fusion protein is called c-MycER. The c-MycER system was first brought forward by Eilers in 1991 [6] and modified by Littlewood in 1995 [16] . It has been proven that c-MycER fusion protein exhibited all c-Myc activities, which was closely dependent upon the synthetic steroid 4-hydroxy-tamoxifen (OHT), yet was totally unresponsive to endogenous steroid and phenol red in medium. D106-143c-myc, encoding a 106-143 amino acid deleted c-Myc, was also fused with HBD cDNA and transfected CHO cells. D106-143c-Myc protein showed no c-Myc activities. We found that the transcriptional expressions of some proposed c-myc target genes including ODC, MrDb, cad, rcc1 and rcl were increased upon OHT induction in CHO-c-mycER cells. In addition, only wild type quiescent CHOc-mycER cells, but not CHO-D106-143c-mycER, CHO-neo or parent CHO cells, could reenter the S phase and subsequently showed apoptotic phenotype after OHT activation. Most importantly, the transcription activation of c-myc target genes was much earlier than the cell behavior change in CHO-c-mycER cells.
MATERIALS AND METHODS

Construction of expression plasmid
The 2.4 Kb wild type c-mycER or 2.3 Kb mutant type D106-143c-mycER cDNAs (gifts of Littlewood) were inserted to the EcoRI site of pcDNA 3 (invitrogen) respectively. The correct orientation was confirmed by sequencing with T7 sequencing TM kit (Pharmacia) according to producer's instruction except for using T7 sequencing primer. The resulting plasmids were named as pcDNA3/c-mycER and pcDNA3/D106-143c-mycER.
Cell culture and establishment of cell lines
Chinese Hamster Ovarian (CHO) cells (Cell Bank, CAS) were grown in Dulbecco s modified Eagle's medium (DMEM, Gibco) supplemented with 10% heat-inactivated newborn bovine serum (NBS, Evergreen), 100 units/ml penicillin, and 100 μg/ml streptomycin. Cells were passaged by standard trypsinization at 70-80% confluence and seeded at 1:4 dilution directly onto tissue culture dishes or flasks. Culture medium was changed every 2 or 3 d to maintain good growth condition. To generate quiescent CHO cells, 2 10 5 exponentially growing cell were seeded to 25 cm 2 flask, medium was changed at 30% confluence (2 d). After 100% confluence (4-5 d), cells were kept in the serum-free medium for another 2 d before they were used for the experiments.
To establish CHO cells with highly expressed wild type c-mycER or mutant type D106-143c-mycER, CHO cells were transfected with pcDNA3/c-mycER or pcDNA3/D106-143c-mycER by the calcium-phosphate method [17] . The cells were cultured for 3 weeks in selection medium [800 g/ml Geneticin (Gibco)] to select stable transfectants. CHO cells were also transfected with pcDNA3 to obtain the CHO-neo control cells. Individual clones were isolated by cloning rings method [18] . Expansion of isolated clones was carried out sequentially in 96-well plate, 24-well plate and finally 25 cm 2 flask in selection medium. The expression of c-mycER or D106-143 c-mycER mRNA in the clones was determined by Northern blot analysis. The c-mycER or D106-143 c-mycER positive clones were then subcloned to get genetically stable and homogeneous cell lines.
Blot analysis
Total cellular RNA was isolated from cells by acid guanidinium thiocyanate phenol-chloroform extraction method [19] . 30 μg of total RNA was size-fractionated on formaldehyde agarose gel, transferred to nylon filter. To do reverse Northern dot hybridization, 100 ng of each cDNA fragment was denatured and dotted directly onto nylon filter. The filter containing DNA or RNA was baked at 80 o C for 2 h. The cross-linked membrane was incubated in prehybridization solution (6 SSC, 5 Denhardt s, 0.5% SDS and 100 μg/ml denatured salmon DNA) at 68 o C for 4 h, then hybridized with 32 P-labelled, denatured DNA probe in hybridization solution (6 SSC, 0.5% SDS, 100 g/ml denatured salmon DNA) at 65 o C for 16-24 h. After hybridization, the filter was washed extensively twice in 2 SSC/0. o C using X-ray film (Kodak) with intensifying screen. The c-myc probe was labeled with a-32P-dCTP (Amersham) using Primer-a-Gene labeling system (Promega) according to producer s instruction. To prepare total cDNA probes for reverse Northern dot hybridization, 5m g mRNA was isolated from total RNA using Quickprep MicromRNA purification kit (pharmacia) and a-32P-dCTP was integrated into the cDNA by reverse transcription with 5 μg oligo(dT)18 as primer.
Morphological, biochemical and quantified analysis of apoptosis
Cells were starved to quiescence as described previously. Medium was changed to serum-free DMEM with or without 200 nM 4-hydroxy-tamoxifen (OHT, Sigma). After 24 h culture, microphotographs were taken and then cells were harvested using trypsin, fixed with 75% ethanol in PBS, and stained for 15 min with 20 μg/ml propidium iodide (PI, Sigma) and 180 μ/ml RNaseA. PI-stained cells were observed with fluorescence microscopy to identify apoptosis by nuclear morphology, or were analyzed by flow cytometry to quantify apoptosis. To identify apoptosis by biochemical character, genomic DNA was extracted from 1 10 6 quiescent, OHT-induced cells and electrophoresed in 2.0% agarose. The DNA laddering was observed by ethidium bromide (EB, Sigma) staining.
RESULTS
Establishment of c-myc overexpressing CHO cell line
Plasmid pcDNA3, pcDNA3/c-mycER or pcDNA3/D106-143c-mycER was introduced respectively to CHO cells by calcium phosphate-DNA coprecipitation method. After G418 selection, individual clones were isolated and expanded. Cellular RNA was extracted and Northern blot hybridization was followed. The representative results were shown in Fig  1. In comparison with parent CHO cells (Fig 1, lane 1) and CHO-neo cells (Fig 1, lane 2) , CHO-c-mycER cells overexpressed c-mycER mRNA (Fig 1, lane 3) and CHO-D106-143c-mycER cells overproduced D106-143c-mycER transcript (Fig 1, lane-4) . However, quiescent parent CHO cells and CHO-neo cells have weakly detected endogenous c-myc expression. 
OHT-dependent c-MycER-promoted transcription
As a transcription factor, c-Myc controls cell destiny by regulating the expression of downstream target genes. Northern blot hybridization was performed to detect the mRNA level of a representative c-myc target gene, ODC. Expression of ODC increased within 3 h after addition of OHT to quiescent CHO-c-mycER cells, and reached a maximum by 9 h. In contrast, addition of OHT to quiescent parent CHO cells did not induce expression of ODC (data not shown). The expression of ODC and other proposed c-myc target genes were c-myc coverexpression induces transcription and apoptosis 
OHT-dependent c-MycER-induced apoptosis
Deregulated expression of c-myc in the absence of growth factors induces apoptosis in fibroblasts. Accordingly, we performed further experiment to test this ability of cMycER in CHO cells. Quiescent, serum-deprived CHO-c-mycER cells underwent death in response to OHT, as demonstrated by microscopic observation (Fig 3) . The rate of cell death was determined by flow cytometry. As shown in Fig 4, CHO-c-mycER cells with OHT displayed a significant rate of apoptosis, whereas CHO-c-mycER cells without OHT and other cell lines with or without OHT all showed low rate of apoptosis which represented inherent low level cell death, not related to OHT induction. The dying cell exhibited nuclear condensation (Fig 5) , a classic character of apoptosis. Degradation of cellular DNA into nucleosomal fragments, a frequent feature of apoptosis, was also evident (Fig 6) . 
DISCUSSION
In our present c-myc overexpressing system, c-Myc is rendered functionally OHTdependent through fusion with the mutant HBD of estrogen receptor [16] . c-MycER protein is probably inactive in the absence of the ligand (OHT) because it complexes with a variety of intracellular polypeptides, of which Hsp90 is prototype. OHT's binding to HBD Fang CM et al.
releases the chimeric protein from the inhibitory complexes.
Although other methods have been used to produce inducible c-myc (i. e. heat or Zn 2+ -inducible) expression system, c-MycER system, which is regulated at protein function level, offers several advantages [20] . The most significant merit is that the response of cMycER to OHT is tightly controlled, relatively fast and readily reversible. The only drawback is that OHT can be toxic to some cells at concentrations above 1 μM. However, OHT is usually added to medium at concentrations far below the lethal limit (ranging from 1 to 200 nM).
As an immediate early gene, c-myc expression is rapidly induced following mitogenic stimulation and is absolutely dependent on growth factors. When serum or specific growth factors are withdrawn, c-myc expression is down-regulated and cells eventually accumulate in the G 0 /G 1 phase of the cell cycle [21] . In order to investigate the roles of exogenous c-MycER on growth and death of CHO cells, it is necessary to arrest CHO cells in G 0 /G 1 phase to repress the endogenous expression background of hamster c-myc. When confluent CHO cells were kept in serum-free medium for 2 days, more than 85% cells were arrested in G 0 /G 1 phase, and endogenous c-myc expression under these conditions was weakly detected by Northern blot analysis (Fig 1) . The quiescent cells could reentry into the cell cycle after serum stimulation or c-myc expression.
In the present experiment, wild type c-mycER or D106-143c-mycER was introduced into CHO cells to study their respective role in CHO cell growth, transformation and apoptosis. We find that (1) activation of c-MycER by OHT can and is sufficient to drive quiescent serum-deprived CHO cells into the cell cycle (Fig 7) and (2) OHT can promote anchorage-independent growth through activation of c-MycER (data not shown). The observation also suggests that c-MycER protein can induce apoptosis. All of the activities are closely dependent upon the OHT addition and upon the intact c-myc sequence because the D106-143c-mycER does not show any of them, due to its deletion in transactivation domain of c-Myc. However, D106-143c-MycER has a complete DNA binding domain, so it can function as a dominant-negative mutant to suppress the apoptosis caused by low expressed endogenous c-myc under serum deprived condition. As shown in Fig 4, CHO-D106-143c-mycER cells displayed a little lower cell death percentage compared to parent and CHO-neo cells. D106-143c-MycER also exerted a dominant-negative effect on S phase entry of CHO-D106-143c-mycER cells. C-myc controls both proliferation and apoptosis in mammalian cells. Deregulated expression of c-myc induces cells to undergo apoptosis, unless specific signals provided either by cytokines or oncogenes blocking the apoptotic pathway. C-MycER activation in quiescent CHO-c-mycER cells induced S phase reentry and subsequent apoptosis under serum-free medium. Our observation tends to support the conflict model theory which proposed that apoptosis is a conflict between stop (no growth factors) and go (but c-myc is on) signals [22] .
The expression of some c-Myc target genes was also determined by mRNA analysis. ODC is one of the most important Myc target genes. ODC is a rate-limiting enzyme in polyamine biosynthesis, required for DNA synthesis [5] . When overproduced, ODC can c-myc coverexpression induces transcription and apoptosis induce apoptosis (as Myc does) in cells lacking survival factor(s). Furthermore, inhibitors of ODC enzyme activity interfere with Myc-induced apoptosis [5] . We find that ODC is induced to express by OHT addition to the CHO-c-mycER cells. The expression reaches to the maximum at 9 h after OHT induction. The expression of other c-Myc target genes, including MrDb, cad, rcc1 and rcl, also have great change after OHT's adding to CHO-cmycER cells. As downstream target genes, they may all contribute to the function of cmyc played in cell apoptosis in CHO-c-mycER system. Dozen of articles indicated that cmyc target genes were involved in DNA synthesis(ODC and cad), RNA metabolism (eIF-2 , eIF-4E, MrDb and rcc1), cell cycle control(p53 and cdc25A), and chromatin modification (μ prothymosin and TERT) (for review see reference 23). However, the function of these genes and the cross-reaction of these genes in the apoptosis induction in CHO-cmycER cells remained to be understood. Although some c-myc target genes show similar functions to c-myc signal pathway, they all can not substitute c-myc in cell growth and death. The cloning and characterization of new c-myc target gene(s) would contribute to the understanding of the authentic function of c-myc.
